[CLINICAL ASPECTS OF ACTIVATION OF NEUTRALIZED PANCREATIC ENZYMES].
D000681:Amylases; D007611:Aprotinin; D002268:Carboxypeptidases; D002763:Cholecystectomy; D002918:Chymotrypsin; D005705:Gallbladder Diseases; D006801:Humans; D010179:Pancreas; D010189:Pancreatic Juice; D010195:Pancreatitis; D014357:Trypsin; D014361:Trypsin Inhibitors
D014361:Trypsin Inhibitors; D007611:Aprotinin; D000681:Amylases; D002268:Carboxypeptidases; D002918:Chymotrypsin; D014357:Trypsin
AMYLASE; CARBOXYPEPTIDASES; CHOLECYSTECTOMY; CHYMOTRYPSIN; GALLBLADDER DISEASES; KALLIKREIN-TRYPSIN INACTIVATOR; PANCREAS; PANCREATIC JUICE; PANCREATITIS; TRYPSIN; TRYPSIN INHIBITORS
KLINISCHE ASPEKTE DER AKTIVIERUNG NEUTRALISIERTER PANKREASFERMENTE.